Latest filing published 12 Jan 2021 for Trillium Therapeutics Inc., €50k.
Filing timeline
BuySaleInsider track record
James Todd Parsons: trading record in brief
James Todd Parsons discloses dealings in Trillium Therapeutics Inc. to SEC (Form 4). We count 13 filings; the first trade dates from 25 August 2011 and the latest from 8 January 2021.
Sales make up the whole of the open-market record (6 sales, €2.0M). Other entries cover 6 option exercises. Since January 2021: no purchases and 1 sale on the market.
Most recently, on 12 January 2021, the filings show an option exercise worth €50k in Trillium Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James Todd Parsons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,505 shares@ CA$9.2036.8% of flowCommon SharesTSXSEDI:3661524
- 8,505 shares@ CA$15.787363.2% of flowCommon SharesTSXSEDI:3661528
- 21,046 shares@ CA$0.38Common SharesTSXSEDI:3646462
- 65,104 shares@ CA$4.23Common SharesTSXSEDI:3646473
- 65,104 shares@ CA$12.7172Common SharesTSXSEDI:3646474
- 21,046 shares@ CA$11.63Common SharesTSXSEDI:3646464
- 14,162 shares@ CA$11.311Common SharesTSXSEDI:3646471
- 14,162 shares@ CA$0.38Common SharesTSXSEDI:3646467
- 43,092 shares@ CA$0.77Common SharesTSXSEDI:3646455
- 106,908 shares@ CA$0.77Common SharesTSXSEDI:3646382
- 43,092 shares@ CA$11.63Common SharesTSXSEDI:3646458
- 106,908 shares@ CA$11.7448Common SharesTSXSEDI:3646384
- Common SharesTSXSEDI:3646381
13 of 13 declarations